To further substantiate our ex vivo findings, we examined the cellular expression/localization levels of SOX2, PI3KR1, OCT3/4, N-Cadherin, E-Cadherin, Nanog, LIF, and CD44 in residual PC. This evidence concerns the gene CD44 and pachyonychia congenita.